logo
Plus   Neg
Share
Email

Roche: FDA Grants Polivy Accelerated Approval - Quick Facts

Swiss drug major Roche (RHHBY) announced Tuesday that the US Food and Drug Administration or FDA has granted accelerated approval to Polivy (polatuzumab vedotin-piiq) in combination with bendamustine plus Rituxan (rituximab) or BR. The approval is for the treatment of adults with relapsed or refractory (R/R) diffuse large B-cell lymphoma or DLBCL, who have received at least two prior therapies.

The approval for this indication was based on complete response rates observed in a randomised, controlled phase Ib/II GO29365 clinical trial.

The company noted that the new targeted medicine was shown to improve clinical outcomes in people with relapsed or refractory diffuse large B-cell lymphoma compared to a commonly used regimen.

The US FDA granted Priority Review for the company's Biologics License Application for Polivy in February 2019.

Further, Roche announced that Peter Voser will step down as a member of the Board at the end of June.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Department of Justice has reached a settlement agreement with a Texas-based Taco Bell franchise owner for immigration-related discrimination against certain employees. The settlement resolves the DOJ's investigation into whether MUY Brands LLC, and a related management company, MUY Consulting Inc., violated the Immigration and Nationality Act. Starbucks is gearing up for the upcoming holiday season by introducing its 2019 holiday flavors in U.S. grocery stores. The launch of the coffee giant's holiday line-up this year includes returning holiday favorites as well as a new item. Customers can now take home products that are making a comeback such as Starbucks Holiday Blend K-Cup and Ground Coffee, Peppermint Mocha Flavored Ground Coffee, Peekay International issued a recall of 7 ounce and 14 ounce packs containing Keshav Dry Apricot food treats as they contain undeclared allergens such as sulfites, according to a statement published by The U.S. Food and Drug Administration. Consumption of the product by those allergic or having severe sensitivity to sulfites could run the risk of serious or life-threatening allergic reactions.
Follow RTT
>